• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.

作者信息

Haga Takahiro, Fujimura Taku, Aiba Setsuya

机构信息

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

J Dermatol. 2019 Jun;46(6):e208-e209. doi: 10.1111/1346-8138.14770. Epub 2019 Jan 21.

DOI:10.1111/1346-8138.14770
PMID:30663155
Abstract
摘要

相似文献

1
Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.采用口服S-1单药疗法成功治疗人中的微囊性附属器癌。
J Dermatol. 2019 Jun;46(6):e208-e209. doi: 10.1111/1346-8138.14770. Epub 2019 Jan 21.
2
The first reported case of metastatic microcystic adnexal carcinoma in an adolescent.首例青少年转移性微囊性附属器癌病例报告。
Dermatol Surg. 2015 Feb;41(2):286-8. doi: 10.1097/DSS.0000000000000258.
3
Squamoid Eccrine Ductal Carcinoma: The Scripps Experience.鳞状样小汗腺导管癌：斯克里普斯医院的经验
Dermatol Surg. 2021 Aug 1;47(8):1115-1117. doi: 10.1097/DSS.0000000000002906.
4
Sweat gland carcinoma with lung metastases.伴有肺转移的汗腺癌。
J Cancer Res Ther. 2006 Oct-Dec;2(4):209-11. doi: 10.4103/0973-1482.29836.
5
A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.一例下睑晚期皮肤鳞状细胞癌患者，采用替吉奥单药治疗获得成功。
J Am Acad Dermatol. 2012 Nov;67(5):e233-4. doi: 10.1016/j.jaad.2012.04.038.
6
A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.一项多中心 II 期研究显示，口服氟嘧啶 S-1 辅助化疗非小细胞肺癌的完成率和生存率较高。
Clin Lung Cancer. 2012 Nov;13(6):464-9. doi: 10.1016/j.cllc.2012.01.005. Epub 2012 Mar 14.
7
[Tegafur/gimeracil/oteracil (Teysuno), by oral administration].替吉奥（替加氟/吉美嘧啶/奥替拉西钾），口服给药。
J Pharm Belg. 2013 Dec(4):35-6.
8
Supraorbital neuroma masquerading as local recurrence from a previously excised microcystic adnexal carcinoma.额部神经瘤伪装为先前切除的微小囊性附件腺癌的局部复发。
J Plast Reconstr Aesthet Surg. 2010 Mar;63(3):e239-41. doi: 10.1016/j.bjps.2009.07.013. Epub 2009 Aug 3.
9
Microcystic adnexal (sclerosing sweat duct) carcinoma of intraoral minor salivary gland origin: an extracutaneous adnexal neoplasm?
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Sep;112(3):284-6. doi: 10.1016/j.tripleo.2011.02.050.
10
How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?对于头颈部鳞状细胞癌，我们应该持续使用S-1作为辅助化疗多长时间？
Acta Otolaryngol. 2015;135(10):1079-85. doi: 10.3109/00016489.2015.1049664. Epub 2015 May 25.

引用本文的文献

1
Current Treatment Options for Cutaneous Adnexal Malignancies.皮肤附件恶性肿瘤的现行治疗选择。
Curr Treat Options Oncol. 2022 May;23(5):736-748. doi: 10.1007/s11864-022-00971-3. Epub 2022 Mar 26.
2
Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back.背部携带基质金属蛋白酶28的微囊性附属器癌
Case Rep Oncol. 2021 Dec 13;14(3):1773-1778. doi: 10.1159/000520971. eCollection 2021 Sep-Dec.
3
Microcystic adnexal carcinoma of the scalp treated with surgical resection along with chemoradiation: A case report and review of the literature.
头皮微囊性附属器癌采用手术切除联合放化疗治疗：一例病例报告及文献复习
Saudi J Biol Sci. 2021 Dec;28(12):7117-7124. doi: 10.1016/j.sjbs.2021.08.002. Epub 2021 Aug 5.
4
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.具有大汗腺和小汗腺分化的皮肤附件肿瘤的当前诊断和治疗选择。
Int J Mol Sci. 2021 May 11;22(10):5077. doi: 10.3390/ijms22105077.
5
Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the Literature.面部微囊性附属器癌的根治性放化疗：病例报告及文献复习
Adv Radiat Oncol. 2019 Dec 13;5(2):301-310. doi: 10.1016/j.adro.2019.11.008. eCollection 2020 Mar-Apr.